Skip to content
sellWeak

Morris Scott James sold $2.4M of FRPT

President at Freshpet, Inc.. 15,000 shares at an average of $157.68, traded Nov 25, 2024, filed Nov 27, 2024.

Warning score
35
Value
$2.4M
15,000 shares
Holdings after
122,380
-11% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0000929638-24-004121, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Nov 25, 2024MOption exercise
Common Stock
+10,000$8.90$89k132,380Nov 27, 2024
Nov 25, 2024SOpen-market sale
Common Stock
-10,000$157.45$1.6M122,380Nov 27, 2024
Nov 26, 2024MOption exercise
Common Stock
+5,000$8.90$45k127,380Nov 27, 2024
Nov 26, 2024SOpen-market sale
Common Stock
-5,000$158.13$791k122,380Nov 27, 2024
Nov 25, 2024MOption exercise
Options to purchase common stockderivative
-10,000$0.00$045,868Nov 27, 2024
Nov 26, 2024MOption exercise
Options to purchase common stockderivative
-5,000$0.00$040,868Nov 27, 2024

Related signals

Other insiders at Freshpet, Inc. and this insider’s other filings.

ScoreSideCompanyInsiderValueSharesFiled
42Moderatebuy 2FRPT
Freshpet, Inc.
MCLEVISH TIMOTHY R
director
$155k1,750
41Moderatebuy 6FRPT
Freshpet, Inc.
GEORGE WALTER N.
director
$45k500
42Moderatebuy 6FRPT
Freshpet, Inc.
GEORGE WALTER N.
director
$48k500
30Weakbuy 6FRPT
Freshpet, Inc.
Fajemirokun-Beck Olufunlayo Olurinde
director
$25k227
30Weakbuy 6FRPT
Freshpet, Inc.
BREWSTER DARYL G
director
$25k241
51Moderatebuy 6FRPT
Freshpet, Inc.
Biegger David
director
$161k1,500
37Weakbuy 6FRPT
Freshpet, Inc.
GEORGE WALTER N.
director
$51k500
45Moderatebuy 6FRPT
Freshpet, Inc.
MCLEVISH TIMOTHY R
director
$210k2,000
45Moderatebuy 6FRPT
Freshpet, Inc.
Steeneck Craig D.
director
$213k2,000
27WeaksellFRPT
Freshpet, Inc.
Morris Scott James
President
$787k5,000

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Morris Scott James sold $2.4M of FRPT | InsiderTell